title: [Osteoporosis--current diagnostics and therapy].
abstract: Osteoporotic fractures are a frequent cause of disability and a loss of quality of life in old age. Maintenance of muscle function and balance, a daily calcium intake of 1,000 mg, sufficient vitamin D, and a prudent use of fall- and osteoporosis-associated drugs are key components of fracture prevention. The German guideline recommends to initiate a specific long-term osteoporosis medication in individuals with a 30% 10-year risk for hip fractures and vertebral fractures.
authors.affiliation: Klinik für Innere Medizin III, Alfried Krupp Krankenhaus-Steele, Essen, Germany. Johannes.Pfeilschifter@krupp-krankenhaus.de
authors.forename: Johannes
authors.initials: J
authors.lastname: Pfeilschifter
mesh_terms: D015502:Absorptiometry, Photon; D000058:Accidental Falls / Q000517:prevention & control; D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004305:Dose-Response Relationship, Drug; D015444:Exercise; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006620:Hip Fractures / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D053580:Muscle Strength; D010024:Osteoporosis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D004856:Postural Balance; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013974:Thyroxine / Q000008:administration & dosage / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage
chemical_list: D050071:Bone Density Conservation Agents; D014807:Vitamin D; D013974:Thyroxine; D002118:Calcium
references.citation: JAMA. 2005 Nov 9;294(18):2336-41
references.pmid: 16278362
references.citation: Osteoporos Int. 2006;17(11):1584-91
references.pmid: 16917676
references.citation: N Engl J Med. 2007 Nov 15;357(20):2028-39
references.pmid: 18003959
references.citation: Osteoporos Int. 2008 Nov;19(11):1613-20
references.pmid: 18483689
references.citation: J Clin Densitom. 2007 Jan-Mar;10(1):102-10
references.pmid: 17289532
references.citation: Calcif Tissue Int. 2008 Apr;82(4):288-92
references.pmid: 18404243
references.citation: Bone. 2007 Sep;41(3):308-17
references.pmid: 17644058
references.citation: Curr Med Res Opin. 2008 Sep;24(9):2669-77
references.pmid: 18694543
references.citation: Am J Med. 1993 Jun;94(6):646-50
references.pmid: 8506892
references.citation: Ann Intern Med. 2001 Apr 3;134(7):561-8
references.pmid: 12803168
references.citation: BMJ. 2008 Feb 2;336(7638):262-6
references.pmid: 18198394
references.citation: Bone. 2004 Aug;35(2):375-82
references.pmid: 15268886
references.citation: Am J Clin Nutr. 2008 Apr;87(4):1080S-6S
references.pmid: 18400738
references.citation: Osteoporos Int. 2009 May;20(5):811-7
references.pmid: 19002369
references.citation: J Clin Endocrinol Metab. 2008 Dec;93(12):4873-9
references.pmid: 18827001
references.citation: J Bone Miner Res. 2008 Oct;23(10):1569-75
references.pmid: 18505366